Hoffmann OI - Search Results

1

Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer.

Hoffmann OI, Regenauer M, Czogalla B, Brambs C, Burges A, Mayer B. Hoffmann OI, et al. Cancers (Basel). 2022 May 3;14(9):2279. doi: 10.3390/cancers14092279. Cancers (Basel). 2022. PMID: 35565408 Free PMC article.

2

Impact of the spheroid model complexity on drug response.

Hoffmann OI, Ilmberger C, Magosch S, Joka M, Jauch KW, Mayer B. Hoffmann OI, et al. J Biotechnol. 2015 Jul 10;205:14-23. doi: 10.1016/j.jbiotec.2015.02.029. Epub 2015 Mar 3. J Biotechnol. 2015. PMID: 25746901 Free article.

3

Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids.

Halfter K, Hoffmann O, Ditsch N, Ahne M, Arnold F, Paepke S, Grab D, Bauerfeind I, Mayer B. Halfter K, et al. J Transl Med. 2016 May 3;14(1):112. doi: 10.1186/s12967-016-0855-3. J Transl Med. 2016. PMID: 27142386 Free PMC article.

4

Multiparametric ¹⁸F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.

Umutlu L, Kirchner J, Bruckmann NM, Morawitz J, Antoch G, Ting S, Bittner AK, Hoffmann O, Häberle L, Ruckhäberle E, Catalano OA, Chodyla M, Grueneisen J, Quick HH, Fendler WP, Rischpler C, Herrmann K, Gibbs P, Pinker K. Umutlu L, et al. Cancers (Basel). 2022 Mar 29;14(7):1727. doi: 10.3390/cancers14071727. Cancers (Basel). 2022. PMID: 35406499 Free PMC article.

5

In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not with Disseminated Tumor Cells.

Kasimir-Bauer S, Karaaslan E, Hars O, Hoffmann O, Kimmig R. Kasimir-Bauer S, et al. Cancers (Basel). 2022 Jul 6;14(14):3299. doi: 10.3390/cancers14143299. Cancers (Basel). 2022. PMID: 35884360 Free PMC article.

6

Multimodal Targeted Deep Sequencing of Circulating Tumor Cells and Matched Cell-Free DNA Provides a More Comprehensive Tool to Identify Therapeutic Targets in Metastatic Breast Cancer Patients.

Keup C, Storbeck M, Hauch S, Hahn P, Sprenger-Haussels M, Hoffmann O, Kimmig R, Kasimir-Bauer S. Keup C, et al. Cancers (Basel). 2020 Apr 27;12(5):1084. doi: 10.3390/cancers12051084. Cancers (Basel). 2020. PMID: 32349306 Free PMC article.

7

Multiparametric Integrated ¹⁸F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding.

Umutlu L, Kirchner J, Bruckmann NM, Morawitz J, Antoch G, Ingenwerth M, Bittner AK, Hoffmann O, Haubold J, Grueneisen J, Quick HH, Rischpler C, Herrmann K, Gibbs P, Pinker-Domenig K. Umutlu L, et al. Cancers (Basel). 2021 Jun 11;13(12):2928. doi: 10.3390/cancers13122928. Cancers (Basel). 2021. PMID: 34208197 Free PMC article.

8

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer.

Keup C, Storbeck M, Hauch S, Hahn P, Sprenger-Haussels M, Tewes M, Mach P, Hoffmann O, Kimmig R, Kasimir-Bauer S. Keup C, et al. Cancers (Basel). 2019 Feb 18;11(2):238. doi: 10.3390/cancers11020238. Cancers (Basel). 2019. PMID: 30781720 Free PMC article.

9

Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI-Clinically Relevant?

Jannusch K, Bruckmann NM, Geuting CJ, Morawitz J, Dietzel F, Rischpler C, Herrmann K, Bittner AK, Hoffmann O, Mohrmann S, Quick HH, Umutlu L, Antoch G, Kirchner J. Jannusch K, et al. Cancers (Basel). 2022 Jul 15;14(14):3454. doi: 10.3390/cancers14143454. Cancers (Basel). 2022. PMID: 35884513 Free PMC article.

10

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.

Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber RD, de Azambuja E, Fielding A, Balmaña J, Domchek SM, Gelmon KA, Hollingsworth SJ, Korde LA, Linderholm B, Bandos H, Senkus E, Suga JM, Shao Z, Pippas AW, Nowecki Z, Huzarski T, Ganz PA, Lucas PC, Baker N, Loibl S, McConnell R, Piccart M, Schmutzler R, Steger GG, Costantino JP, Arahmani A, Wolmark N, McFadden E, Karantza V, Lakhani SR, Yothers G, Campbell C, Geyer CE Jr; OlympiA Clinical Trial Steering Committee and Investigators. Tutt ANJ, et al. N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3. N Engl J Med. 2021. PMID: 34081848 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page